Best Health Care Grants in Puerto Rico

The David C. J. Peters Scholarship, established by Southland Industries in honor of ASHRAE member David Peters, offers a one-year scholarship to qualified undergraduate students in mechanical or architectural engineering. Candidates must be enrolled full-time in a bachelor's program at designated institutions and maintain a minimum GPA of 3.0 or be in the top 30% of their class. This initiative supports the mission of ASHRAE to promote sustainable practices in engineering.

The ASHRAE Presidents Scholarship supports full-time students pursuing a Bachelor of Science in engineering, focusing on HVAC and refrigeration. To qualify, applicants must have a minimum GPA of 3.0 and complete at least 45 credit hours with two years remaining before graduation. Scholarships are awarded for the upcoming academic year, beginning in the fall semester, and re-applications are welcomed from previous applicants who meet current criteria.

The NINDS Exploratory Clinical Trials for Small Business (R41/R42) program supports Small Business Concerns in conducting investigator-initiated exploratory clinical trials. This funding opportunity emphasizes projects that align with the NINDS mission, evaluating diverse products including drugs, biologics, and devices. Only STTR Phase II and Fast-Track applications are eligible, fostering innovation in neurological disorder treatments. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 30 days prior to the deadline.

The NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) grant supports small businesses in conducting innovative clinical trials relevant to neurological disorders. This funding opportunity encourages investigator-initiated projects evaluating drugs, devices, and therapies aligned with NINDS goals. Applications are accepted only from SBIR Phase II and Fast-Track applicants, with a submission deadline of 5:00 PM local time. Letters of Intent are encouraged 30 days prior to the full proposal deadline.

The DoW Spinal Cord Injury Translational Research Award supports innovative research to transform promising spinal cord injury findings into clinical applications. It features an Early-Career Partnership Option, requiring at least one early-career principal investigator. Collaborations with SCI community partners are essential for providing guidance throughout the project. This funding opportunity aims to enhance the effectiveness of spinal cord injury interventions and improve patient outcomes.

The Miniaturization and Automation of Tissue Chip Systems (MATChS) initiative by the NIH aims to advance biomedical research through the development of automated tissue chip platforms. This program encourages small businesses to propose innovative technologies that enhance data acquisition and analysis while minimizing manual handling. Funded projects will create efficient, miniaturized systems vital for drug development and other research applications. Collaboration with NIH staff is expected to ensure milestones and commercial pathways are effectively established.

The Limited Competition Small Grant Program supports NCATS CTSA Program KL2 scholars, enhancing their transition to independent academic translational scientists. This R03 funding facilitates various research projects, including pilot studies and methodology development, aimed at generating preliminary data for future R01 applications. The program is designed for short-term projects utilizing limited resources, promoting innovative research in clinical and translational science.

The Miniaturization and Automation of Tissue Chip Systems (MATChS) initiative supports the development of advanced technologies for automated tissue chip platforms. This funding opportunity, provided by the NIH, aims to enhance drug development and biomedical research by enabling high-throughput automated measures and online data analysis. Successful applications will demonstrate collaboration with NIH staff to achieve project milestones and pathways to commercialize these innovative systems, ultimately increasing the accessibility of miniaturized solutions in research.

The Aging Research Dissertation Awards aim to enhance diversity in the scientific workforce by funding research on aging and related health conditions. The program encourages applicants from underrepresented backgrounds to apply for dissertation awards that align with the National Institutes of Health's strategic priorities. Key deadlines for applications include February 16, June 16, and October 16 for the years 2024 through 2026.

The Elks National Foundation's Legacy Awards provide $4,000 scholarships for children and grandchildren of Elks members. Eligible applicants must be high school seniors and can apply online. The program supports educational pursuits at accredited U.S. institutions, ensuring that the legacy of community service and support continues. With criteria focusing on family connections to the Elks and a commitment to education, these awards promote opportunities for future generations to thrive and contribute to society.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The NCI Pathway to Independence Award (K99/R00) aims to support early-stage postdoctoral researchers transitioning to independent faculty positions. This initiative focuses on talented individuals with doctoral degrees in research or clinical fields, providing essential NCI funding during this key career juncture. Researchers engaged in cancer control, prevention, and data sciences are encouraged to apply for this opportunity, which emphasizes experimental studies with human participants, thus aligning with NIH's clinical trial definitions.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers aiming to transition to independent faculty positions. It encourages candidates with doctoral degrees in research or clinical fields to apply, particularly those in cancer control and prevention. This funding opportunity facilitates a quick shift from mentored research to independent careers, providing essential support for awardees to establish competitive research programs without leading their own clinical trials.

The Limited Competition grant supports High Impact Specialized Innovation Programs to enhance clinical and translational science capabilities at UM1 CTSA Program Hubs. Eligible applicants include primary UM1 CTSA hub organizations, aiming to address significant gaps in research and development. Successful proposals will foster foundational innovations for broader dissemination among CTSA hubs, paving the way for future advancements in clinical practices and research methodologies.

The Leukemia & Lymphoma Society's Equity in Access Research Grants aim to enhance equitable access to care for blood cancer patients and survivors. This program funds research to identify effective interventions that increase participation in clinical trials among underrepresented groups. Projects can receive up to $500,000 annually for a maximum of five years, with a total budget cap of $2.5 million. The initiative seeks to address systemic barriers that hinder clinical trial enrollment and improve healthcare access.

The NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3) invites applications for the execution of investigator-initiated, interventional clinical trials across various phases. This program supports researchers in finalizing preparations necessary for trial initiation, including IRB establishment and staffing. Successful UG3 projects may transition to the UH3 phase, emphasizing the need for hypothesis-driven studies with significant clinical impact within NIAMS's research mission.

The Chick-fil-A Community Scholars program awards up to thirteen $25,000 scholarships annually to students demonstrating academic excellence, community service, and financial need. In addition to financial support, recipients participate in a year-long mentoring and leadership development program. This initiative aims to cultivate future leaders who are committed to serving their communities, while also alleviating educational costs associated with attending accredited colleges or vocational schools.

The NIAID Research Education Program (R25) fosters diverse research careers by supporting educational activities for individuals from underrepresented backgrounds in biomedical sciences. This program encourages skills development, research experiences, and mentoring activities to enhance career trajectories. Key deadlines for grant applications include January 25 and May 25 from 2024 to 2026, with additional deadlines for AIDS-related applications. This initiative aligns with NIH's mission to diversify the research workforce.

The HEAL Initiative aims to develop non-addictive therapeutics for pain management through small molecules and biologics. This funding opportunity supports preclinical optimization, facilitating the transition of promising candidates to clinical trials. Important proposal deadlines span from January 2024 to January 2027, with optional Letters of Intent encouraged 30 days prior. The program emphasizes collaboration with NIH staff to ensure thorough project planning and monitoring, aiming to revolutionize pain treatment while ensuring safety and efficacy.

The Live Your Dream Awards, sponsored by Soroptimist International of the Americas, empower women by providing vital monetary assistance for their education and training. Each year, over $3 million is awarded to more than 2,300 women who are the primary financial support for their families. This initiative supports those overcoming significant challenges like poverty and domestic violence, ensuring they have the resources to achieve their dreams and live fulfilling lives.

The FY26 Melanoma Research Program Focused Program Award for Rare Melanomas supports multidisciplinary research initiatives aimed at addressing critical questions in rare melanomas. This award requires collaboration between an Initiating Principal Investigator and up to two Partnering PIs, with the inclusion of a rare melanoma survivor or patient advocate in the project team. Approximately $5.6M is allocated to fund two awards, each capped at $2.8M, over a maximum performance period of four years.

The AAFP Foundation offers Family Medicine Chapter Engagement Grants to support the philanthropic initiatives of its constituent chapters. Each chapter or chapter foundation can receive $750 to highlight programs focused on Student/Resident education, Member Outreach, or Public Health. This initiative not only showcases the impactful work being done at the chapter level but also aids in fundraising efforts, fostering stronger community connections and improving health outcomes.

The EPSCoR Research Infrastructure Improvement-Focused Collaborations Program (RII-FEC) aims to enhance research capabilities in eligible jurisdictions by fostering partnerships among government, higher education, and industry. This program supports interdisciplinary teams of researchers to tackle significant challenges in STEM fields, promoting diversity and broadening participation. By integrating Minority-Serving Institutions and early-career faculty from underrepresented backgrounds, RII-FEC seeks to build sustainable STEM capacity and drive impactful discoveries across regions.

The Lung Cancer Translational Research Award (TRA) for FY26 supports innovative translational research aimed at transforming promising lung cancer ideas into clinical applications. This award emphasizes advanced preclinical studies and pilot clinical trials of novel interventions, addressing critical research areas within the Lung Cancer Research Program. Applicants can choose between two funding levels to advance their impactful studies, thereby contributing to significant advancements in lung cancer treatment.

The Lung Cancer Patient-Centered Outcomes and Survivorship Award (PCOSA) aims to enhance health outcomes for lung cancer patients by promoting patient-centered research. This FY26 initiative encourages projects that address key areas of survivorship and requires the involvement of lung cancer survivors or caregivers in research teams. Additionally, it supports both translational and clinical research, including pilot clinical trials, to improve the overall patient experience.

The EPSCoR Centers of Research Excellence in Science and Technology initiative, led by the National Science Foundation, aims to enhance the research capabilities of EPSCoR jurisdictions. By fostering STEM capacity and promoting geographic diversity, this program invites proposals that align with its goals. The focus is on strengthening local research infrastructure and talent development to boost competitiveness in science and technology fields across the nation.

The FY26 Lung Cancer Research Program's Idea Development Award supports innovative, high-risk research aimed at significant breakthroughs in lung cancer treatment. It encourages new concepts in their early stages, requiring preliminary data to demonstrate feasibility, although not necessarily from lung cancer studies. This program also features a New Investigator category, allowing early-career researchers to compete separately for funding, fostering a diverse range of impactful investigations.